Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ellis Bixler"'
Publikováno v:
Open Forum Infectious Diseases
Background Cell-free DNA (cfDNA) has emerged as an important clinical specimen to probe for pathogenic microbes, especially in organ transplant patients where the same data can be used to predict allograft rejection. Recent reports described viral, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21761ac161acbda20b0a5668d6925c7a
https://doi.org/10.1093/ofid/ofaa439.1395
https://doi.org/10.1093/ofid/ofaa439.1395
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S337-S338
Introduction Viral infections are commonly reported in immunocompromised patients such as hematopoietic stem cell transplant recipients. While there are several reports on the effect of individual viruses, such as CMV, there is increasing evidence th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31068a792233a7d2d34cc7ca27c341bf
https://doi.org/10.1016/j.bbmt.2019.12.368
https://doi.org/10.1016/j.bbmt.2019.12.368
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S344-S345
Background Antiviral resistance to human cytomegalovirus (CMV) is an important complication for immunocompromised patients on prolonged antiviral regimens, and CMV remains the most clinically significant infection following allogeneic hematopoietic-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97557dcc1e028f771ecc641224ef622f
https://doi.org/10.1016/j.bbmt.2018.12.558
https://doi.org/10.1016/j.bbmt.2018.12.558
Publikováno v:
Open Forum Infectious Diseases
Background Antiviral resistance to human cytomegalovirus (CMV) is a growing concern for immunocompromised patients on prolonged antiviral regimens, and CMV remains the most clinically significant infection following allogeneic hematopoietic-cell tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f897f738fc118278968a23e349c492
http://europepmc.org/articles/PMC6255564
http://europepmc.org/articles/PMC6255564
Autor:
James L.M. Ferrara, Mark C. Wissel, Ryan K. Shields, Ellis Bixler, Mauricio Miralles, Brad Schindel, Michelle Altrich, George Morales, Manisha Diaz, Steve Kleiboeker
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S226
Introduction aGVHD affects 40% to 60% of hematopoietic cellular transplant (HCT) patients, targeting the skin, liver, and gastrointestinal tract with a median onset approximately 1 month after transplant. In 2017, an interpretive algorithm based on s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d4603d41719d323ea13040b6d4c94d8
https://doi.org/10.1016/j.bbmt.2018.12.215
https://doi.org/10.1016/j.bbmt.2018.12.215